Search

for
Search:

Sort by

Research

30 / 1000+ results

Double-Blind Randomized Placebo-Controlled Study of the Efficacy and Safety of Hair Loss Prevention Shampoo Containing Salicylic Acid, Panthenol, and Niacinamide in Alopecia Patients

research Double-blind randomized placebo-controlled study of the efficacy and safety of hair loss prevention shampoo containing salicylic acid, panthenol, and niacinamide in alopecia patients

1 citations , April 2022 in “Toxicology and Environmental Health Sciences”

The shampoo with salicylic acid, panthenol, and niacinamide is effective and safe for preventing hair loss in people with alopecia.

research A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania

180 citations , November 1991 in “American Journal of Psychiatry”

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Sesquiterpene-Enriched Extract of Curcuma Aeruginosa Roxb. Retards Axillary Hair Growth: A Randomized, Placebo-Controlled, Double-Blind Study

research Sesquiterpene-Enriched Extract of Curcuma aeruginosa Roxb. Retards Axillary Hair Growth: A Randomised, Placebo-Controlled, Double-Blind Study

5 citations , January 2018 in “Skin Pharmacology and Physiology”

Curcuma aeruginosa extract lotion significantly reduces underarm hair growth.

Supplementary Material for: Sesquiterpene-Enriched Extract of Curcuma Aeruginosa Roxb. Retards Axillary Hair Growth: A Randomised, Placebo-Controlled, Double-Blind Study

research Supplementary Material for: Sesquiterpene-Enriched Extract of Curcuma aeruginosa Roxb. Retards Axillary Hair Growth: A Randomised, Placebo-Controlled, Double-Blind Study

January 2018 in “Figshare”

Curcuma aeruginosa extract lotion effectively reduces underarm hair growth.

research A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of Latanoprost for Eyelash Growth in Aesthetic Medicine

2 citations , October 2023 in “Cosmetics”

Latanoprost effectively and safely promotes eyelash growth.

Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

research Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

136 citations , April 2016 in “Dermatologic Surgery”

PRP treatment helps hair growth and density in androgenetic alopecia patients.

research Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia

87 citations , September 2016 in “Dermatologic Surgery”

PRP shows potential for treating female hair loss, but more research needed.

research A double-blind, placebo-controlled study of inositol in trichotillomania

18 citations , November 2016 in “International clinical psychopharmacology”

Inositol was not more effective than a placebo in treating trichotillomania.

research Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia

3 citations , May 2017 in “Dermatologic Surgery”

PRP may help treat female hair loss, but more research needed.

The Efficacy of Subcutaneous Slow-Release Melatonin Implants in the Prevention of Canine Flank Alopecia Recurrence Is Uncertain: A Double-Blind, Randomized, Placebo-Controlled Study

research The efficacy of subcutaneous slow‐release melatonin implants in the prevention of canine flank alopecia recurrence is uncertain: A double‐blind, randomized, placebo‐controlled study

3 citations , September 2022 in “Veterinary Dermatology”

Melatonin implants did not effectively prevent hair loss in dogs.

A Prospective Double-Blind Placebo-Controlled Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

research A Prospective Double-Blind Placebo Controlled Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

January 2017

Platelet-rich plasma treatment significantly improved hair density and regrowth in both men and women suffering from pattern hair loss, with even better results when combined with certain medications.

A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia

research A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia

81 citations , August 2011 in “Journal of The American Academy of Dermatology”

Latanoprost 0.1% may effectively treat hair loss.

research Latanoprost and minoxidil: Comparative double-blind, placebo-controlled study for the treatment of hair loss

January 2018 in “Surgical and Cosmetic Dermatology”

Latanoprost and minoxidil effectively control hair loss and increase hair count.

research A Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Anti-Skin-Aging Effect of LactoSporin – The Extracellular Metabolite from Bacillus coagulans (Weizmannia coagulans) MTCC 5856 in Healthy Female Volunteers

16 citations , March 2023 in “Clinical Cosmetic and Investigational Dermatology”

LactoSporin cream reduces wrinkles and improves skin texture safely.

research A double-blind, placebo-controlled study with Kevis lotion

4 citations , January 1989

An Oral French Maritime Pine Bark Extract Improves Hair Density in Menopausal Women: A Randomized, Placebo-Controlled, Double-Blind Intervention Study

research An oral French maritime pine bark extract improves hair density in menopausal women: A randomized, placebo‐controlled, double blind intervention study

January 2023 in “Health science reports”

French maritime pine bark extract significantly increased hair density in menopausal women.

research Skin and Scalp Health Benefits of a Specific Botanical Extract Blend: Results from a Double-Blind Placebo-Controlled Study in Urban Outdoor Workers

3 citations , August 2024 in “Cosmetics”

A botanical extract blend improved skin and scalp health in women working outdoors.

research Antihirsutism activity of Fennel (fruits of Foeniculum vulgare) extract – A double-blind placebo controlled study

59 citations , January 2003 in “Phytomedicine”

Fennel extract cream can reduce hair thickness in people with excessive hair growth.

A Double-Blind, Randomized, Placebo-Controlled Pilot Study to Investigate the Effects of Finasteride Combined with a Biodegradable Self-Reinforced Poly L-Lactic Acid Spiral Stent in Patients with Urinary Retention Caused by Bladder Outlet Obstruction

research A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly l-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from

30 citations , July 2001 in “BJUI”

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Minoxidil 2% Lotion for Eyebrow Enhancement: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Comparative Study

research Minoxidil 2% lotion for eyebrow enhancement: A randomized, double-blind, placebo-controlled, spilt-face comparative study

13 citations , November 2013 in “The Journal of Dermatology”

Minoxidil 2% lotion is safe and effective for making eyebrows thicker and fuller.

Commentary on a Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

research Commentary on a Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia

4 citations , March 2016 in “Dermatologic Surgery”

PRP treatment increased hair density, especially in men and younger patients with AGA.

A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia

research A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia

August 2025 in “Cureus”

The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.

research A randomized, double blind, placebo controlled, split patch study to evaluate the effects of platelet rich plasma on alopecia areata

July 2018 in “International Journal of Research in Medical Sciences”

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

Efficacy, Safety, and Tolerability of Dutasteride 0.5 mg Once Daily in Male Patients with Male Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study

research Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study

92 citations , June 2010 in “Journal of The American Academy of Dermatology”

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

research Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study

65 citations , March 1999 in “Urology”

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

Safety and Clinical Efficacy of Kūlaris, an Herbal Supplement for Mild to Severe Acne Vulgaris: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study

research Safety and Clinical Efficacy of KūlarisTM, an Herbal Supplement for Mild to Severe Acne Vulgaris – A 12-Week Randomized, Double Blind, Placebo-Controlled Study

September 2025 in “Clinical Cosmetic and Investigational Dermatology”

Kūlaris improved quality of life for acne sufferers without side effects.

research Faculty Opinions recommendation of Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia.

May 2016 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

A Prospective, Randomized Double-Blind, Placebo-Controlled Study for Safety and Efficacy of SesZen-Bio: A Proprietary Sesbania Grandiflora Extract in Managing Hair and Scalp Health in Healthy Adults

research A prospective, randomized double-blind, placebo-controlled study for safety and efficacy of SesZen-BioTM: a proprietary Sesbania grandiflora extract in managing hair and scalp health in healthy adults

April 2024 in “International journal of clinical trials”

SesZen-Bio™ improves hair density, thickness, and overall hair health.

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair

research A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair

January 2025 in “Journal of Cosmetic Dermatology”

The supplement improved hair growth and quality in men with thinning hair and was safe to use.

A 6-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of a Marine Complex Supplement to Promote Hair Growth in Men with Thinning Hair

research A 6-month, randomized, double-blind, placebo-controlled study evaluating the ability of a marine complex supplement to promote hair growth in men with thinning hair

25 citations , August 2016 in “Journal of Cosmetic Dermatology”

The marine complex supplement significantly improved hair growth in men with thinning hair without adverse effects.